icrf 193 has been researched along with fluorouracil in 1 studies
| Studies (icrf 193) | Trials (icrf 193) | Recent Studies (post-2010) (icrf 193) | Studies (fluorouracil) | Trials (fluorouracil) | Recent Studies (post-2010) (fluorouracil) |
|---|---|---|---|---|---|
| 155 | 0 | 30 | 45,562 | 9,307 | 14,663 |
| Protein | Taxonomy | icrf 193 (IC50) | fluorouracil (IC50) |
|---|---|---|---|
| Epidermal growth factor receptor | Homo sapiens (human) | 0.32 | |
| Thymidylate synthase | Mus musculus (house mouse) | 1.58 | |
| Aromatase | Homo sapiens (human) | 0.63 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cleveland, JL; Fee, BE; Hiebert, SW; Nip, J; Strom, DK; Zambetti, G | 1 |
1 other study(ies) available for icrf 193 and fluorouracil
| Article | Year |
|---|---|
E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis.
Topics: Antineoplastic Agents; Apoptosis; Bone Marrow Cells; Carrier Proteins; Cell Cycle; Cell Cycle Proteins; Cell Survival; Diketopiperazines; DNA Damage; DNA-Binding Proteins; Doxorubicin; E2F Transcription Factors; E2F1 Transcription Factor; Enzyme Inhibitors; Etoposide; Fluorouracil; Gamma Rays; Gene Expression; Humans; Piperazines; Proto-Oncogene Proteins c-bcl-2; Retinoblastoma-Binding Protein 1; Topoisomerase II Inhibitors; Transcription Factor DP1; Transcription Factors; Tumor Suppressor Protein p53 | 1997 |